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Abstract: Background: To compare the clinical outcomes of wavefront-optimized (WFO) transepithelial
photorefractive keratectomy (trans-PRK) and corneal wavefront-guided (CWFG) trans-PRK for myopic eyes with
moderate to high astigmatism.
Methods: One hundred ninety-six eyes (196 patients) with moderate to high astigmatism (≥ 1.75 D) treated with WFO
or CWFG trans-PRK (101 and 95 eyes, respectively) were retrospectively registered. Safety, efficacy, predictability, vector
analysis, and corneal aberrations were compared between groups preoperatively and at 6 months postoperatively.
Results: At postoperative 6 months, the mean logMAR uncorrected distance visual acuity was similar in the WFO
(− 0.07 ± 0.08) and CWFG (− 0.07 ± 0.07) groups. Safety, efficacy, and predictability of refractive and visual outcomes were
also similar. The correction indices were 1.02 ± 0.14 and 1.03 ± 0.13 in the WFO and CWFG groups, respectively, with no
significant difference. The absolute values of the angle of error were significantly higher in the WFO group (2.28 ± 2.44 vs.
1.40 ± 1.40; P = 0.002). Corneal total root mean square higher-order aberrations and corneal spherical aberrations
increased postoperatively in both groups; however, the change was smaller in the CWFG group. Corneal coma showed a
significant increase postoperatively only in the WFO group.
Conclusions: WFO and CWFG trans-PRK are safe and effective for correcting moderate to high astigmatism. However,
CWFG trans-PRK provides a more predictable astigmatism correction axis and fewer induced corneal aberrations.
Keywords: Transepithelial photorefractive keratectomy, Wavefront-optimized, Corneal Wavefront-guided, Astigmatism
Background
Transepithelial photorefractive keratectomy (trans-PRK)
is an alternative to conventional PRK, and removes the
epithelium via laser phototherapeutic keratectomy [1].
Initially, trans-PRK was a two-step surgery in which the
corneal epithelium was removed first and then the
stroma was ablated; hence, it was not widely used due to
longer operating times, higher pain scores, and a defi-
ciency of adequate nomograms [2]. However, single-step
trans-PRK (SCHWIND Eye-Tech-Solutions GmbH and
Co KG, Kleinostheim, Germany) has been widely used
in the field of refractive surgery since its release [3, 4].
This technique combines epithelial ablation, which
ablates 55 μm at the center and 65 μm at the periphery,
according to a previous epithelial profile study [5], with
ablation of the stroma, into a single continuous profile
[4]. Several previous studies have shown that transe-
pithelial ablation shortens the operative time and re-
duces early postoperative pain, haze formation, and the
epithelial healing period [3, 4].
Higher-order aberrations (HOAs) have become an im-
portant issue in refractive surgery field, because HOAs
can affect postoperative visual quality [6]. Glare, halos,
haze, or starbursts can occur due to the generation of
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incidental HOAs after ablation of the cornea. Two treatment
profiles, wavefront-optimized (WFO) and wavefront-guided
(WFG), are widely employed to reduce the postoperative in-
duction of HOAs [7, 8]. Numerous studies have compared
the clinical outcomes in WFO and WFG treatments [6, 7, 9].
Both profiles reduced HOAs and glare symptoms, and in-
creased mesopic contrast sensitivity and patient preference
[6, 10–13]. Recently, a study that compared WFO and cor-
neal WFG (CWFG) trans-PRK showed that both modalities
are excellent and safe for correction of myopia, while CWFG
trans-PRK has some advantages in postoperative HOAs over
the WFO profile [1].
However, few studies have compared the astigmatic
vector parameters between WFO and WFG treatments
[14–16]. Recently, a study comparing the efficacy of
astigmatic correction between WFO and WFG profiles
in LASIK surgery reported that WFG LASIK resulted in
better astigmatism correction and visual outcome com-
pared to that for WFO LASIK [16]. However, reports
comparing the clinical outcomes and vector parameters
in WFO and WFG for patients with moderate to high
astigmatism have not yet been published.
Trans-PRK is an efficient and safe treatment modality
for the correction of high myopia [17, 18]; however, there
are currently no studies on trans-PRK in patients with
high astigmatism. Furthermore, while WFO trans-PRK
vector analyses have been reported [17–19], a vector ana-
lysis of CWFG trans-PRK has not yet been performed.
Thus, the aim of the current study was to evaluate the
clinical outcomes, including visual acuity, refractive error,
vector parameters, and aberrometric changes, in
aberration-free (AF; WFO treatment) and CWFG (WFG
treatment) trans-PRK in patients with moderate to high
astigmatism.
Methods
Subjects
This study is a retrospective, comparative, observational
case series, and was approved by the Institutional Review
Board of the Yonsei University College of Medicine
(Seoul, South Korea; IRB No. 4–2017-0260). The study
followed the tenets of the Declaration of Helsinki. The
enrolled patients underwent WFO trans-PRK or CWFG
trans-PRK performed by a single, experienced surgeon
(DSK) at the Eyereum Eye Clinic in Seoul, Korea be-
tween October 2014 and February 2017.
The inclusion criteria were as follows: < 10.00 diopters
(D) of myopia with ≥1.75 D of refractive astigmatism,
18–40 years of age, stable refraction for at least 1 year,
more than 300 μm of residual stromal thickness, and a
corrected distance visual acuity (CDVA) of 0.8 Snellen
fractions or better. The level of moderate to high astig-
matism was set at 1.75 D or more, in accordance with a
previous study [20, 21]. All subjects did not wear contact
lenses for at least 3 weeks before the preoperative exam-
ination. Exclusion criteria were as follows: severe ocular
surface disease, including Stevens-Johnson syndrome,
graft-versus-host disease, or Sjogren syndrome; corneal
epithelial pathology, such as recurrent corneal erosion
or epithelial defects; keratoconus; cataracts; previous in-
traocular or corneal surgery; a history of glaucoma; and
any posterior segment pathology. We retrospectively
reviewed the medical records of 196 eyes (196 patients)
satisfying the study criteria. The right or left eye was
randomly chosen, regardless of ocular dominance, re-
fraction, and aberrations.
Preoperative and postoperative assessments
Before surgery, all patients underwent a detailed ophthal-
mological examination, including an evaluation of the un-
corrected distance visual acuity (UDVA) and CDVA,
manifest refraction, slit-lamp examination (Haag-Streit,
Köniz, Switzerland), intraocular pressure measurement
(noncontact tonometer; NT-530, NCT Nidek Co., Ltd.,
Aichi, Japan), autokeratometry (ARK-530A autokeratome-
try; Nidek Co., Ltd., Aichi, Japan), central corneal thickness
(CCT) using ultrasound pachymetry (UP-1000;Nidek), and
Scheimpflug-based corneal topography (Pentacam HR,
Oculus, Wetzlar, Germany). Visual acuity was mea-
sured monocularly at 6 m with a Snellen chart (con-
verted to the logMAR scale for statistical analysis).
Manifest refraction was performed by one ophthalmologist.
Multiple corneal indices were measured at the 8-mm zone
using the Scheimpflug tomography system (Pentacam HR;
OCULUS). Corneal wavefront aberrations were measured
using the Keratron Scout (Optikon 2000, Rome, Italy). The
examinations performed preoperatively were also per-
formed at postoperative 1 month, 3 months, and 6 months.
The baseline (preoperative) and 6-month postoperative
data were analyzed.
Surgical technique
Ablation profile planning was performed using the
integrated Optimized Refractive Keratectomy-Custom
Ablation Manager software package (version 5.1, Schwind
eye-tech-solutions GmbH and Co KG) and was based on
clinical parameters, including manifest refraction, pachyme-
try, and corneal wavefront data (up to the seventh order;
obtained using Keratron Scout). The surgeon could change
the optical zone diameter and select the aberrations to be
treated. For corneal wavefront–guided treatments, all
HOAs were treated with the corneal wavefront–guided ab-
lation profile. A static cyclotorsion compensation algorithm
profile was used, and dynamic cyclotorsion control was im-
plemented automatically for all treatments. Centration on
the corneal vertex was ensured by input from the topog-
rapher. In CWFG treatments, all HOAs were treated using
the CWFG ablation profile.
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Topical proparacaine hydrochloride 0.5% (Alcaine;
Alcon Laboratories, Inc., Fort Worth, TX, USA) drops
were instilled in the upper and lower fornices. The eyes
were then scrubbed and draped, and a lid speculum was
inserted between the lids of the eye to be treated. The
other eye was occluded. The epithelium and stroma
were ablated using a single continuous profile with the
SCHWIND Amaris 1050RS excimer laser platform.
Ablation profiles used were the aspheric AF (WFO treat-
ment) or customized full corneal WFG ablation profiles,
calculated using the ORK-CAM software module
(SCHWIND eye-tech-solutions GmbH and Co KG).
Postoperatively, Mitomycin-C (0.02%) was applied for 30 s,
and the eye was then irrigated. Topical levofloxacin 0.5%
(Cravit; Santen Pharmaceutical, Osaka, Japan) was applied at
the surgical site, and a bandage contact lens (Acuvue Oasys;
Johnson & Johnson Vision Care, Inc., Jacksonville, FL, USA)
was fitted on to the cornea for 4–5 days until epithelial
healing was complete. After surgery, topical levofloxacin
0.5% and fluorometholone 0.1% (Flumetholon; Santen
Pharmaceutical, Osaka, Japan) were applied 4 times per day
for 1 month. The dosage was gradually reduced over a
period of 3 months.
Statistical analysis
Results are expressed as mean ± standard deviation or
mean ± standard error. Group differences were evaluated
using Student’s t-test or the Mann-Whitney U test, ac-
cording to Levene’s test. Linear regression analyses were
performed to compare the achieved versus attempted
outcomes. Statistical analyses were performed using
SPSS statistics software (version 23; IBM Corporation,
Armonk, NY, USA). Differences were considered statisti-
cally significant when the p value was 0.05 or less.
Results
The WFO group included 101 eyes, while the CWFG
group included 95 eyes. The baseline characteristics are
provided in Table 1. There were no significant group dif-
ferences in laterality, age, or sex. Additionally, the mean
preoperative spherical equivalent and cylinder were
comparable, and there were no significant group differ-
ences in the preoperative UDVA, CDVA, CCT, optical
zone, or Pentacam indices. The total ablation zone and
the maximum ablation depth were significantly smaller
in the WFO group compared to that in the CWFG
group, despite the comparable optical zones.
Visual acuity, efficacy, and safety
At postoperative 6 months, there were significant im-
provements in the mean UDVA, relative to preoperative
values, in both the WFO (from 1.30 ± 0.34 to − 0.07 ±
0.08) and CWFG groups (from 1.25 ± 0.33 to − 0.07 ±
0.07) (both p < 0.001; Tables 1 and 2). In addition, the
Table 1 Characteristics of eyes that underwent WFO trans-PRK and those that underwent CWFG trans-PRK
Characteristics WFO Trans-PRK CWFG Trans-PRK P value
Number of eyes 101 (R: L = 50: 51) 95 (R: L = 46: 49) .879
Sex M: F = 53: 48 M: F = 49: 46 .900
Age, years old 22.96 ± 2.82 (20 to 33) 23.99 ± 4.78 (18 to 38) .070
Refractive errors (D)
Sphere −4.91 ± 1.77 (− 8.25 to 0.12) −4.54 ± 2.16 (− 8.12 to 0.25) .191
Cylindrical −2.41 ± 0.64 (− 4.25 to − 1.75) −2.36 ± 0.62 (− 4.50 to − 1.75) .593
SE −6.11 ± 1.78 (− 9.19 to − 1.68) −5.72 ± 2.08 (− 9.00 to − 1.50) .155
logMAR CDVA − 0.06 ± 0.08 (− 0.18 to 0.10) −0.06 ± 0.07 (− 0.18 to 0.10) .817
logMAR UDVA 1.30 ± 0.34 (0.40 to 2.00) 1.25 ± 0.33 (0.30 to 1.70) .234
CCT 541.83 ± 31.02 (480 to 613) 538.79 ± 25.46 (470 to 590) .455
Optical zone (mm) 6.40 ± 0.25 (6.00 to 6.90) 6.42 ± 0.27 (6.00 to 7.00) .549
Total ablation zone (mm) 8.07 ± 0.15 (7.57 to 8.4) 8.14 ± 0.20 (7.53 to 8.64) .005a
Maximum ablation depth (μm) 142.01 ± 32.71 (60.02 to 202.00) 153.31 ± 29.61 (65.04 to 200.71) .012a
Q value −0.33 ± 0.12 (− 0.72 to − 0.10) −0.32 ± 0.13 (− 0.62 to 0.00) .844
Index of surface variance 25.59 ± 4.78 (17 to 36) 25.59 ± 4.98 (17 to 38) .999
Index of height asymmetry 5.99 ± 5.77 (0.1 to 27.8) 4.97 ± 3.06 (0.5 to 14.8) .312
Index of vertical asymmetry 0.13 ± 0.06 (0.05 to 0.32) 0.13 ± 0.05 (0.04 to 0.27) .823
Index of height decentration 0.009 ± 0.006 (0.000 to 0.029) 0.008 ± 0.004 (0.001 to 0.020) .755
Results are expressed as means ± standard deviation
WFO wavefront-optimized, CWFG corneal wavefront-guided, Trans-PRK transepithelial photorefractive keratectomy, D diopters, SE spherical equivalent, logMAR
logarithm of the minimum angle of resolution, CDVA corrected distance visual acuity, UDVA uncorrected distance visual acuity, CCT central corneal thickness,
asignificantly different between aberration-free and corneal wavefront-guided groups using t-test
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UDVA was 20/12.5 or better in 33 (33%) and 22 (23%)
eyes, 20/16 or better in 60 (59%) and 64 (67%) eyes, and
20/20 or better in 96 (95%) and 93 (98%) eyes in the
WFO and CWFG groups, respectively (Fig. 1a). Treated
eyes improved in UDVA, in both the WFO and CWFG
groups, with 21 (21%) and 20 (21%) eyes gaining one or
more lines in the UDVA at postoperative 6 months rela-
tive to the preoperative CDVA, (Fig. 1b). None of the
eyes in either group lost two or more lines of CDVA at
6 months postoperatively (Fig. 1c). Six months postoper-
atively, the mean efficacy index (ratio of the postopera-
tive UDVA to preoperative CDVA) was 1.05 ± 0.12 for
the WFO group and 1.05 ± 0.12 for the CWFG group,
with no significant group difference (p = 0.858). The
mean safety index (ratio of the postoperative to pre-
operative CDVA) was 1.07 ± 0.14 for the WFO group
and 1.09 ± 0.17 for the CWFG group, with no significant
group difference (p = 0.586).
Refraction
The mean manifest refraction spherical equivalent (MRSE)
significantly improved after trans-PRK in both groups
(Tables 1 and 2, p < 0.001). The accuracy of the refractive
correction was excellent (Fig. 1d−g). The achieved SE was
within 1.0 D of the intended SE for all treated eyes
(both groups). In the linear regression analysis of the
attempted versus achieved SE for each technique, the
slope and coefficient (R2) of were 1.009 and 0.9800,
respectively, in the WFO group, and 0.9778 and
0.9835, respectively, in the CWFG group. In terms of
astigmatism, 89 (88%) eyes in the WFO group and 88
(93%) eyes in the CWFG group had less than 0.5 D
cylinder postoperatively. In the linear regression ana-
lysis of the target-induced astigmatism vector versus
the surgically-induced astigmatism vector for each
technique, the slope and coefficient (R2) were 0.9733
and 0.8020, respectively, in the WFO group, and
0.9615 and 0.8173, respectively, in the CWFG group.
Vector analysis
Using the Alpins method, a vector analysis of astigma-
tism was performed [22, 23]. Table 3 provides the vector
analysis results for the 6-month postoperative refractive
data. There were no significant group differences in the
target-induced astigmatism (TIA), surgically-induced
astigmatism (SIA), difference vector (DV), and correc-
tion index (CI) (Table 3). In addition, there were no sig-
nificant group differences in the index of success (IOS),
arithmetic values of the angle of error (AofE), and mag-
nitude of error (MofE). However, the absolute values of
the AofE were 2.28 ± 2.44 in the WFO group, and 1.40 ±
1.40 in the CWFG group, with a significant group differ-
ence (p = 0.002). Because of the symmetric mirror effect
in the axis of astigmatism between the right and left eyes
[24], we analyzed each eye separately. In the WFO
group, the arithmetic values of the AofE were negative
for the right eye (i.e., counter-clockwise rotation of
achieved correction vectors relative to the original
TIAs), but were positive for the left eye (i.e., clockwise
rotation of achieved correction vectors relative to the
original TIAs). In contrast, the arithmetic values of the
AofE were negative for both the right and left eye in the
CWFG group. Figure 2 provides polar diagrams of the
TIA, SIA, DV, and CI (using the same axes), which were
comparable in the two groups.
Correlation analyses between refractive correction and
preoperative refractive error or offset
There were no significant correlations between attempted
SE and SE error (attempted minus achieved SE) in either
group (Fig. 3a). Moreover, no significant correlation was
noted between TIA and MofE in either group (Fig. 3b).
There was no significant interaction between angle kappa
and refractive outcomes, including vector parameters
(Fig. 4), and no differences were noticed in the linear
regression analysis between the WFO group and the
CWFG group.
Higher-order aberrations
Table 4 presents the corneal aberration data. The total
corneal RMS HOAs were significantly increased after
surgery in both groups (p < 0.001). However, the RMS
HOAs at 6 months postoperative were significantly
smaller in the CWFG group compared to those in the
Table 2 Postoperative visual acuity and refractive errors
WFO Trans-PRK CWFG Trans-PRK P value
logMAR UDVA −0.07 ± 0.08 (− 0.18 to 0.10) −0.07 ± 0.07 (− 0.18 to 0.05) .954
logMAR CDVA −0.08 ± 0.08 (− 0.18 to 0.10) −0.09 ± 0.07 (− 0.18 to 0.05) .896
Sphere (D) 0.35 ± 0.27 (− 0.12 to 1.00) 0.32 ± 0.28 (− 0.25 to 1.00) .455
Cylindrical (D) −0.33 ± 0.24 (− 1.00 to 0.00) −0.27 ± 0.19 (− 0.75 to 0.00) .076
SE (D) 0.19 ± 0.26 (− 0.38 to 0.88) 0.19 ± 0.27 (− 0.38 to 0.88) .953
Comparison of postoperative visual acuity and refractive errors between patients who underwent WFO Trans-PRK and those who underwent CWFG Trans-PRK
Results are expressed as means ± standard deviation (range)
WFO wavefront-optimized, CWFG corneal wavefront-guided, Trans-PRK transepithelial photorefractive keratectomy, logMAR logarithm of the minimum angle of
resolution, UDVA uncorrected distance visual acuity, SE spherical equivalent
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Fig. 1 Visual outcomes after WFO and CWFG trans-PRK in moderate to high astigmatism. (a) Cumulative 6-months postoperative uncorrected
distance visual acuity (UDVA) and preoperative corrected distance visual acuity (CDVA). Snellen line changes in postoperative UDVA (b) and CDVA
(c), relative to preoperative CDVA values, are shown. The accuracy of the spherical equivalent refraction (SEQ) to the intended target (d), and
attempted versus achieved change in SEQ (e) at postoperative 6 months are shown. The relative distribution of preoperative and postoperative
6-months cylinder (f) and target-induced versus surgically induced astigmatism (g) at postoperative 6 months are shown. (h) The refractive
astigmatism angle of error distribution at postoperative 6 months. Data are presented as mean ± standard deviation. WFO, wavefront-optimized;
CWFG, corneal wavefront-guided; trans-PRK, transepithelial photorefractive keratectomy
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WFO group. Delta values, which represent the change
between preoperative and postoperative values, were also
significantly smaller in the CWFG group compared to
those in the WFO group (Table 4 and Fig. 5). Corneal
spherical aberrations significantly increased from pre-
operative values in both groups (p < 0.001). Both the ab-
solute and delta spherical aberration values were
significantly smaller in the CWFG group compared to
those in the WFO group. Corneal coma increased sig-
nificantly after surgery in the WFO group (relative to
preoperative values), but remained the same in the
CWFG group (p < 0.001 and p = 0.777, respectively). The
delta coma values were significantly higher in the WFO
group compared to the CWFG group (p = 0.007). In con-
trast, the postoperative corneal trefoil values remained
at preoperative levels in both the WFO and CWFG
groups, with no significant between-group difference.
Discussion
WFO and WFG treatments have mainly been evaluated
with regard to visual acuity, correction of refractive er-
rors, and HOAs; few studies have compared the treat-
ments using astigmatism vector analysis [14–16].
Furthermore, an evaluation of astigmatic correction in
patients with moderate to high astigmatism and a com-
parison of WFG and WFO profiles in trans-PRK were
Fig. 3 (a) SEQ error versus attempted SEQ at 6 months after surgery. (b) Magnitude of error versus target-induced astigmatism vector at
6 months after surgery. WFO, wavefront-optimized; CWFG, corneal wavefront-guided; SEQ, spherical equivalent; D, diopter
Fig. 2 Single angle polar plots of the target-induced astigmatism vector (a), surgically-induced astigmatism vector (b), difference vector (c), and
correction index (d) after wavefront-optimized (WFO) and corneal wavefront-guided (CWFG) transepithelial photorefractive keratectomy (trans-
PRK) at 6 months postoperatively
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lacking. Thus, we evaluated the clinical outcomes and
vector parameters after WFO and CWFG trans-PRK in
myopic eyes with moderate to high astigmatism.
Similar to previous studies [1, 4, 25, 26], the postoper-
ative outcomes of WFO and CWFG trans-PRK in our
study demonstrate that both methods are efficient and
safe for treating moderate to high astigmatism. The
treatments did not significantly differ in postoperative
visual acuity or refractive errors. In addition, the efficacy
and safety indices were comparable and there was no
significant relationship between the attempted SE and
SE error in either group (Fig. 3a).
Moreover, the mean CI values—the ratios of the TIA to
the SIA—were approximately 1, and the mean MofE values,
which represent the difference between the attempted and
achieved astigmatism vector, were low in both groups, indi-
cating that both treatment modalities are equally efficacious
and predictable in terms of correction of astigmatism.
There was no significant relationship between TIA and
MofE in either group (Fig. 3b). A previous study using vec-
tor analysis showed good astigmatism correction in
trans-PRK, comparable to that for alcohol-assisted PRK
[17]. However, we found little difference in the astigmatic
correction axis between the two profiles of trans-PRK. The
AofE values were significantly higher in the WFO group
compared to those in the CWFG group; although the dif-
ference might seem small, a 4-degree axis difference can
theoretically result in a 14% undercorrection in astigmatism
[27]. The slightly larger (nonsignificant; p = 0.078) DV
values in the WFO group may have been related to the
Fig. 4 (a) SEQ error versus preoperative offset. (b) Difference vector versus preoperative offset. (c) Magnitude of error versus preoperative offset.
(d) Absolute value of magnitude of error versus preoperative offset. (e) Angle of error versus preoperative offset. (f) Absolute value of angle of
error versus preoperative offset. WFO, wavefront-optimized; CWFG, corneal wavefront-guided; SEQ, spherical equivalent; D, diopter
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higher values of the absolute AofE. A previous study re-
ported absolute AofE values of 1.9 ± 0.67 for WFG LASIK
and 9.7 ± 3.70 for WFO LASIK, with a significant group
difference; however the groups did not differ in DV, CI,
IOS, and MofE [14]. Kalifa and colleagues also reported
that the AofE is significantly better in moderate myopic
eyes after WFG LASIK; furthermore, WFG LASIK showed
significantly better results in DV, CI, and MofE compared
to that for WFO LASIK [16]. Another study examining
WFG and WFO PRK reported that WFO PRK elicited a
higher absolute AofE and comparable DV, CI, IOS, and
MofE to that observed in WFG PRK [15]. Given these re-
sults, including the present results, we can infer that the
WFG profile is superior to the WFO profile in astigmatism
correction, especially in terms of the AofE. In addition, the
arithmetic AofE values were negative in the right eye and
positive in the left eye in the WFO group in the present
study, while the AofE values were negative in both the right
and left eyes in the CWFG group. These data suggest that
while the WFO profile in trans-PRK can be influenced by
eye laterality, the CWFG profile is not.
We analyzed whether the angle kappa is associated with
refractive outcomes. There were no significant relation-
ships between offset and refractive outcomes, including
SE error, DV, MofE, and AofE (Fig. 4). Both treatments
were performed under centration to the corneal vertex;
hence, the angle kappa was effectively compensated for,
and no difference was noted between the two groups.
Although the corneal RMS HOAs significantly in-
creased after treatment in both groups, the amount of
change was significantly larger in the WFO group at
6 months postoperative. Reduced induction of RMS
HOAs in the CWFG group can result in better visual
quality. Similarly, corneal spherical and coma aberra-
tions were also increased after trans-PRK in both pro-
files, but to a lesser extent in CWFG trans-PRK.
Numerous previous studies have shown that the WFG
profile has some advantages in HOAs induction after
refractive surgery over the WFO profile, consistent
with the results of the present study [1, 7, 16, 28,
29]. There is only one previous study that compared
WFO and CWFG trans-PRK; no significant group
differences in the induction of spherical aberrations
were observed [1]. In contrast, the present study
showed greater spherical aberration induction in
WFO trans-PRK compared to that in CWFG
trans-PRK in patients with moderate to high astig-
matism. In addition, corneal coma was significantly
increased after surgery in the WFO group, but not
in the CWFG group, similar to the results of a pre-
vious study [1]. These results suggest that the
CWFG profile may have some benefits over the
WFO profile in treating moderate to high astigma-
tism. The total ablation zone and the maximum ab-
lation depth were significantly larger in the CWFG
group despite of comparable OZ between the groups,
as we previously reported [1]. This might be associ-
ated with less induction of HOAs.
The present study has several limitations. Mainly, it
was not designed as a prospective randomized trial
and had a relatively short follow-up period. Despite
these limitations, we believe the current study is of
value, as it is the first investigation comparing the
WFO and CWFG profiles in eyes with moderate to
high astigmatism in terms of clinical outcomes and
vector parameters. Thus, our study results can aid
Fig. 5 Changes in HOAs at 6 months after WFO and CWFG trans-PRK in moderate to high astigmatism. Data are presented as mean ± SEM. RMS,
root mean square; SphAb, spherical aberration; ns, not significant; *, significant. HOAs, higher order aberrations; WFO, wavefront-optimized; CWFG,
corneal wavefront-guided; trans-PRK, transepithelial photorefractive keratectomy
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surgeons who treat myopic eyes with moderate to
high astigmatism using trans-PRK.
Conclusions
Both WFO and CWFG profiles elicited excellent, safe,
and predictable visual outcomes and refraction in the
treatment of moderate to high astigmatism. However,
the CWFG profile showed better results with regard
to the astigmatism correction axis. Moreover, the in-
duced corneal HOAs after treatment were signifi-
cantly less with the CWFG profile compared to that
with the WFO profile.
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